Medicines & pharmacies
Bringing personal medicines into China
Identify every ingredient, check current Customs and controlled-substance rules, prepare traceable evidence, and declare without assuming clearance.
A foreign prescription is medical evidence, not a Chinese import permit or a promise of border release. Under the current Customs framework effective from 1 April 2025, passenger baggage must be truthfully declared and satisfy the personal-use and reasonable-quantity principle, while prohibited, restricted, controlled and public-health-sensitive articles can follow additional rules. The active ingredient, product form, traveller, itinerary, quantity and documents all matter. This R1 guide maps the administrative workflow for a person carrying medicine in their own baggage. It does not publish an allowed-medicines list, calculate a quantity, select or substitute a medicine, change a dose or treatment plan, classify an ingredient conclusively, provide legal representation, or guarantee airline acceptance, Customs release, duty treatment, onward supply or later pharmacy access.
Use this as a practical starting point
Provider procedures can change, so confirm time-sensitive details with the hospital, insurer or service. A licensed professional must make clinical decisions for an individual patient.
At a glance
Key points
- Start with every active ingredient and product form, not the foreign brand name, package colour or overseas prescription status.
- Use the current 2025 Customs baggage rules; older pages and screenshots may reproduce procedures that have been superseded.
- Separate ordinary personal baggage, controlled-substance rules, public-health-sensitive articles, carrier restrictions and commercial import routes.
- China applies personal-use and reasonable-quantity principles; there is no safe universal number for every medicine, traveller or trip.
- Narcotic drugs and psychotropic substances are defined through official catalogues that can change, so obtain current classification confirmation for uncertain ingredients.
- A prescription, diagnosis letter, original package and translation can support identity and personal use but do not override a prohibition, permit requirement or Customs decision.
- Where written declaration is required—or the traveller does not understand the rule or cannot choose a channel—use the red channel and complete the declaration before inspection measures begin.
- An electronic pre-entry draft is not completed declaration until the traveller confirms it at the designated Customs point and accepts verification.
- Keep the declaration, inspection, retention, return or release record; do not conceal, relabel, split, post or courier medicine as a workaround.
Define the exact journey and item before checking a rule
Write down who will carry the item, whether it is entering, leaving or transiting mainland China, the arrival and onward ports, the travel dates and the intended length of stay. Passenger baggage, unaccompanied baggage, post, courier, cargo and an institutional import are different regulatory routes. Clearance under one route does not authorize another.
Create one row for each medicine and each presentation. Record the product name exactly as printed, every active ingredient, strength, dosage form, package size, manufacturer, country of supply, number of packages and who prescribed or dispensed it. Keep combination products on one row while listing all ingredients. Do not translate a brand into a guessed Chinese equivalent.
Record the personal-use explanation and the trip period without turning either into a quantity formula. Customs determines reasonable personal use from the actual circumstances and applicable product rules. This website cannot pre-approve an amount or tell a person to alter treatment so that baggage appears easier to clear.
- Carrier and traveller identity
- Entry, exit or transit route
- Exact brand and generic ingredient names
- Strength, dosage form and package count
- Prescriber, dispenser and supply country
- Personal-use purpose and travel period
Check the active ingredient against the right authority
Do not let an overseas label such as prescription, over the counter, supplement, herbal, compounded or legal settle the Chinese classification. First identify the active ingredient and product form. Then check whether a current Chinese narcotic, psychotropic, precursor, prohibited or other special-control rule may apply. Official catalogues are dynamic; an old internet list is not a reliable final check.
The 2024-revised Regulations on the Control of Narcotic Drugs and Psychotropic Drugs define controlled substances through official catalogues. For an individual carrying a narcotic drug or Category I psychotropic drug for treatment, Article 44 contains a specific medical-diagnosis, identity and prescription-cap framework, while Customs still applies personal-use and reasonable principles at the border. That is a category-specific rule, not a universal number for all medicines and not a clearance guarantee.
Use Customs for the passenger-baggage and declaration decision. Use the responsible Chinese drug regulator for a drug-control or catalogue question that Customs directs there. Commercial marketing authorization and institutional special-import licensing are separate from a traveller's baggage assessment; do not submit an enterprise application or assume a medicine is allowed merely because a commercial route exists.
If any ingredient is uncertain, obtain current confirmation from Customs and, where directed, the drug regulator before travel. China Care Desk does not maintain a controlled-substance whitelist.
Separate medicine baggage from public-health-sensitive articles
The current baggage rules separately identify blood and other human tissue, pathogenic microorganisms, biological products and other items related to public-health safety as written-declaration categories. A traveller should not infer that every injectable, refrigerated or biologic-looking medicine belongs to one category, or that a product is ordinary medicine simply because a pharmacy supplied it.
Ask Customs to identify the applicable category and any permit, certificate, inspection or handling requirement for the actual product. Provide the manufacturer description or other authoritative product information it requests. A doctor's letter may explain treatment and personal use, but it cannot replace a permit or public-health requirement owned by another authority.
Transport and clinical handling remain separate. Ask the carrier about cabin, checked-baggage, security and device rules, and ask the dispensing provider or manufacturer about product-specific storage. Do not use this page to improvise temperature control, transfer a product into an unlabelled container, or decide whether a medicine remains usable.
Obtain an item-specific answer before departure
Contact the General Administration of Customs 12360 channel or the Customs authority responsible for the intended port with the complete ingredient worksheet. Ask whether the item requires written declaration, supporting evidence or another authority's approval. State that the medicine will be personally carried; do not ask only whether the brand is legal in China.
Give the travel date because the rule or catalogue may change. Record the office, channel, date, reference number and the exact question and answer. If the answer is oral, ask where the current written rule or service instruction can be found. A pre-travel reply is preparation evidence, not a binding border guarantee, because the inspecting Customs office must assess the actual item and circumstances.
If Customs directs the traveller to a drug regulator, public-health authority or another permit owner, ask that body about the exact ingredient, product form and personal-carriage facts. Do not rely on an airline agent, travel agency, insurer, foreign pharmacy or embassy blog to make the Chinese Customs decision, and do not send a complete medical file to an unverified account.
- Exact active ingredient and product form
- Number and size of packages
- Personal-carriage route and port
- Travel date and intended stay
- Document or permit question
- Official reference number and source URL
Build a traceable evidence packet
Keep the medicine in the manufacturer or dispensing pharmacy's labelled packaging where practicable so that the product, ingredient, strength, holder and supply source can be inspected. Do not hide a label, combine different products in one unmarked container or create a new label yourself. Original packaging is useful identity evidence; this guide does not claim that packaging alone is permission or that every medicine has one universal packaging rule.
Carry the prescription and a current prescriber letter or diagnosis record where available. The record should be authentic, identify the traveller and prescriber, name each medicine and active ingredient, explain that it is for the named person's treatment and state the prescribed supply. Preserve the original and add a clearly marked Chinese or English translation if requested. A translation should not replace the source document or add facts the issuer did not provide.
Add the traveller's identity document, itinerary, pharmacy dispensing label or receipt, product insert and any written Customs or regulator response. Keep a secure backup, but present only what the accountable authority requests. If a controlled category applies, follow its exact current document rule rather than treating this general packet as a substitute.
- Original traveller identity document
- Prescription and prescriber contact
- Diagnosis or treatment-purpose statement
- Complete ingredient and product worksheet
- Original labelled packaging and product insert
- Dispensing evidence where available
- Source-labelled translation if requested
- Official enquiry or permit record where applicable
Use the current written-declaration workflow
Under the current 2025 framework, a traveller carrying an item that requires written declaration completes the paper declaration or electronic declaration data and uses the red channel. A traveller who does not understand the Customs rule or does not know which channel to choose should also use the red channel. A prohibited item is not made permissible by declaration, but concealment or the wrong channel can create an additional compliance problem.
Electronic data can be prepared through the official channels identified by Customs, but the traveller must still confirm the data at the declaration counter or other designated place, present the travel document and supporting evidence, and accept verification. Finish written declaration before Customs begins inspection measures; a draft, screenshot or message to an airline is not completed Customs declaration.
Describe the item factually and consistently with the package and records. Answer questions about ingredient, quantity, use, holder and itinerary without guessing. Ask the officer to identify any missing document or next step in writing where possible. Do not photograph or record in the Customs control area unless permission is given.
Red-channel declaration is a compliance step, not a permit, tax exemption, clinical approval or promise that Customs will release the medicine.
Handle inspection, retention or non-release without improvising
Customs may inspect, question, sample or ask for additional evidence under the current rules. Stay with the process, answer accurately and keep the package, prescription and identity evidence together. If Customs applies a seal, do not open or damage it. If an interpreter assists, the traveller remains responsible for truthful information and should check the translated ingredient and quantity details.
If the matter cannot be completed immediately, ask for the name of the item, the reason, the responsible office, the receipt or retention record, the missing permit or evidence, the deadline and the permitted next actions. Current rules contain different handling and deadline provisions for different categories, including articles that are perishable, easily invalidated or related to public-health safety. Follow the written instruction for the actual item rather than a general internet timeline.
Release, duty payment, temporary storage, return, abandonment and other disposition are different outcomes. Do not sign a form that is not understood, alter a document after submission or assume that a doctor's letter compels release. For an unresolved legal dispute, obtain advice from a qualified professional; this page does not provide representation or predict an appeal outcome.
Keep Customs, airline and later healthcare decisions separate
Airline carriage, airport security, Customs entry, local prescription recognition, pharmacy availability and insurance reimbursement are separate decisions. Airline approval does not bind Customs, and Customs release does not prove that a Chinese clinician or pharmacy can continue the same product. Keep the relevant confirmation and document owner for each step.
If continued treatment in China may be needed, arrange a lawful clinical and pharmacy route in advance where possible. A qualified clinician must decide any medicine change, equivalent product, prescription or dose. Do not ration, stop, substitute or share medicine because an administrative check is uncertain, and do not ask this website to make the treatment decision.
Do not split the supply among travellers, disguise the contents, send more by post or courier, or describe a personal medicine as another item to avoid baggage review. Postal, courier and cargo imports have their own declaration and control rules. Preserve the Customs outcome and use the correct route for any later movement.
Useful language
Navigation phrases
Show the Chinese characters when pronunciation is uncertain. Use the copy button to send one phrase through a trusted channel without retyping it.
Avoidable problems
Common mistakes
- Checking only the foreign brand or overseas prescription status instead of every active ingredient
- Using an old Customs page that reproduces rules superseded by the 2025 baggage framework
- Treating personal use or trip length as a universal quantity formula
- Assuming a narcotic or psychotropic rule applies identically to every controlled category
- Calling every injectable, refrigerated or biological-looking product an ordinary medicine
- Removing products from traceable packaging or creating a home-made label
- Treating a prescription, doctor letter or translation as guaranteed Customs permission
- Assuming an airline answer, embassy note or travel-agent checklist binds Chinese Customs
- Completing an electronic draft but failing to confirm it at the designated declaration point
- Using the green channel when a written declaration is required or the traveller cannot choose confidently
- Ignoring a Customs receipt, seal, evidence request or item-specific deadline
- Splitting, concealing, posting or couriering medicine as a workaround
Common questions
Frequently asked questions
Does a foreign prescription guarantee that Customs will allow the medicine?
No. It can support identity, treatment purpose and personal use, but it does not override a prohibition, controlled-substance rule, permit requirement, inspection or Customs decision. The actual ingredient, product, quantity, traveller and journey still matter.
How much personal medicine can I bring?
There is no safe universal number for every medicine and traveller. Customs applies personal-use and reasonable-quantity principles to the actual circumstances, while some controlled categories have additional rules. Ask Customs about the exact ingredient, product, package count and journey; do not calculate a general allowance from this page.
Does medicine have to remain in original packaging?
Traceable manufacturer or dispensing packaging is strong product-identity evidence and reduces ambiguity, so keep it where practicable. Packaging alone is not permission, and this guide does not claim one universal packaging rule for every item. Ask Customs if repackaging is unavoidable or the label is incomplete.
What should I do if I am unsure whether written declaration is required?
The current baggage rules direct a traveller who does not understand the rule or cannot choose a channel to use the red channel. Ask Customs, complete any required paper or electronic declaration and confirm it at the designated point before inspection. Declaration does not make a prohibited item permissible.
Does an electronic declaration mean the medicine is approved?
No. Electronic data is a way to prepare the declaration. The traveller must confirm it at the designated Customs point, present the travel document and supporting evidence, and accept verification. It is neither pre-clearance nor a release guarantee.
Can I carry a narcotic or psychotropic medicine for treatment?
Do not answer from the brand name alone. The current regulation uses dynamic official catalogues and contains a specific document and prescription-cap framework for an individual carrying a narcotic drug or Category I psychotropic drug for treatment, with Customs still applying personal-use and reasonable principles. Confirm the exact ingredient and current route before travel; this page does not classify it or calculate the amount.
Are biological medicines treated like ordinary tablets?
Not necessarily. Current Customs rules separately identify certain biological and public-health-sensitive articles for written declaration, but appearance or refrigeration alone does not settle classification. Give Customs the exact product and manufacturer information and follow the category it confirms.
Can I post or courier the medicine if passenger carriage is uncertain?
Do not use post or courier as a workaround. Postal, courier, cargo and passenger-baggage routes have different declaration and control rules, and controlled substances can have specific mailing requirements. Ask the responsible authority about the correct route before sending anything.
Evidence
Sources consulted for this guide
National rules are separated from city and provider examples. Access dates show when a source was collected; source pages and procedures can change afterward.